Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?

Rik Brooimans; Vincent van der Velden; N Boeckx; J Slomp; F Preijers; Jeroen te Marvelde; Mai Van; A Heijs; E Huys; Ronnie van der Holt; Georgine Greef; A Kelder; GJ Schuurhuis

doi:10.1016/j.leukres.2018.11.014

Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?

Rik Brooimans, Vincent van der Velden, N Boeckx, J Slomp, F Preijers, Jeroen te Marvelde, Mai Van, A Heijs, E Huys, Ronnie van der Holt, Georgine Greef, A Kelder, GJ Schuurhuis

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)

1 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	39-47
Number of pages	9
Journal	Leukemia Research
Volume	76
DOIs	https://doi.org/10.1016/j.leukres.2018.11.014
Publication status	Published - 2019

Access to Document

10.1016/j.leukres.2018.11.014

REPUB_113113-OA.pdfFinal published version, 1.18 MB

Cite this

Brooimans, R., van der Velden, V., Boeckx, N., Slomp, J., Preijers, F., te Marvelde, J., Van, M., Heijs, A., Huys, E., van der Holt, R., Greef, G., Kelder, A., & Schuurhuis, GJ. (2019). Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible? Leukemia Research, 76, 39-47. https://doi.org/10.1016/j.leukres.2018.11.014

Brooimans, Rik ; van der Velden, Vincent ; Boeckx, N ; Slomp, J ; Preijers, F ; te Marvelde, Jeroen ; Van, Mai ; Heijs, A ; Huys, E ; van der Holt, Ronnie ; Greef, Georgine ; Kelder, A ; Schuurhuis, GJ. / Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?. In: Leukemia Research. 2019 ; Vol. 76. pp. 39-47.

@article{9d31ce44962541a1b805b997c3474bca,

title = "Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?",

author = "Rik Brooimans and {van der Velden}, Vincent and N Boeckx and J Slomp and F Preijers and {te Marvelde}, Jeroen and Mai Van and A Heijs and E Huys and {van der Holt}, Ronnie and Georgine Greef and A Kelder and GJ Schuurhuis",

year = "2019",

doi = "10.1016/j.leukres.2018.11.014",

language = "Undefined/Unknown",

volume = "76",

pages = "39--47",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd.",

}

Brooimans, R , van der Velden, V, Boeckx, N, Slomp, J, Preijers, F, te Marvelde, J , Van, M, Heijs, A, Huys, E, van der Holt, R, Greef, G, Kelder, A & Schuurhuis, GJ 2019, 'Immunophenotypic measurable residual disease (MRD) in acute myeloid leukemia: Is multicentric MRD assessment feasible?', Leukemia Research, vol. 76, pp. 39-47. https://doi.org/10.1016/j.leukres.2018.11.014